Compositions and Methods for Treatment and Prevention of Neurological Disorders
Summary
The European Patent Office published patent EP4165025A2 granted to Yumanity Therapeutics, Inc. covering compositions and methods for treating neurological disorders. The patent claims cover specific chemical compounds classified under A61K 31/5377 and A61K 31/519 with applications for neurological conditions including A61P 25/28. The patent is validated in designated European member states including Germany, France, United Kingdom, Italy, and Spain.
What changed
The European Patent Office published patent application EP4165025A2 for Yumanity Therapeutics, Inc., covering compositions and methods for treating and preventing neurological disorders. The patent claims include heterocyclic compounds classified under C07D 239/00 and C07D 239/48 with therapeutic applications for neurodegenerative conditions.
Pharmaceutical companies and biotech firms developing neurological disorder treatments should review this patent for freedom-to-operate considerations. The validated designations cover major European markets including Germany, France, Italy, Spain, and the United Kingdom, creating potential licensing or collaboration opportunities for parties working in related therapeutic areas.
What to do next
- Monitor patent portfolio for freedom-to-operate implications
- Review compound claims for potential licensing opportunities
- Assess therapeutic applications for neurological disease pipeline
Archived snapshot
Apr 8, 2026GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.
COMPOSITIONS AND METHODS FOR THE TREATMENT AND PREVENTION OF NEUROLOGICAL DISORDERS
Publication EP4165025A2 Kind: A2 Apr 01, 2026
Applicants
Yumanity Therapeutics, Inc.
Inventors
TARDIFF, Daniel, SCANNEVIN, Robert, RHODES, Kenneth
IPC Classifications
A61K 31/5377 20060101AFI20240604BHEP A61K 31/519 20060101ALI20240604BHEP A61P 25/28 20060101ALI20240604BHEP C07D 239/00 20060101ALI20240604BHEP C07D 239/48 20060101ALI20240604BHEP C07D 413/04 20060101ALI20240604BHEP
Designated States
AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR
Related changes
Get daily alerts for ChangeBridge: EPO Bulletin - Organic Chemistry (C07D)
Daily digest delivered to your inbox.
Free. Unsubscribe anytime.
Source
About this page
Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission
Source document text, dates, docket IDs, and authority are extracted directly from EPO.
The plain-English summary, classification, and "what to do next" steps are AI-generated from the original text. Cite the source document, not the AI analysis.
Classification
Who this affects
Taxonomy
Browse Categories
Get alerts for this source
We'll email you when ChangeBridge: EPO Bulletin - Organic Chemistry (C07D) publishes new changes.